All pharmacokinetic data cited here comes from the published Phase 2 trial
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies

Heres how: Choose a lightweight Vitamin C serum (1020%) for daytime brightening and protection, creams or moisturizers with Vitamin C and Glutathione for hydration and repair, and sheet masks infused with both for an instant pre-event glow
Because no empirical data, study design, outcomes, or statistical findings are present in the provided material, a clinically accurate summary for a physician audience cannot be generated from this source
An effective alternative to expensive injections, it naturally increases GLP-1 (glucagon-like peptide-1) hormone levels to reduce appetite, curb cravings &